CA2271582A1 - Procede d'administration d'agents therapeutiques, incluant l'anti-sens avec dosage repetitif - Google Patents
Procede d'administration d'agents therapeutiques, incluant l'anti-sens avec dosage repetitif Download PDFInfo
- Publication number
- CA2271582A1 CA2271582A1 CA 2271582 CA2271582A CA2271582A1 CA 2271582 A1 CA2271582 A1 CA 2271582A1 CA 2271582 CA2271582 CA 2271582 CA 2271582 A CA2271582 A CA 2271582A CA 2271582 A1 CA2271582 A1 CA 2271582A1
- Authority
- CA
- Canada
- Prior art keywords
- lipid
- antisense
- nucleic acid
- peg
- particle
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7895598A | 1998-05-14 | 1998-05-14 | |
| US09/078,955 | 1998-05-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2271582A1 true CA2271582A1 (fr) | 1999-11-14 |
Family
ID=29709302
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA 2271582 Abandoned CA2271582A1 (fr) | 1998-05-14 | 1999-05-13 | Procede d'administration d'agents therapeutiques, incluant l'anti-sens avec dosage repetitif |
Country Status (1)
| Country | Link |
|---|---|
| CA (1) | CA2271582A1 (fr) |
Cited By (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001080900A2 (fr) * | 2000-04-20 | 2001-11-01 | The University Of British Columbia | Procedes permettant d'ameliorer la transfection a mediation splp (particule plasmide-lipide stabilisee) au moyen de destabilisateurs de la membrane endosomale |
| WO2005026372A1 (fr) * | 2003-09-15 | 2005-03-24 | Protiva Biotherapeutics, Inc. | Composes conjugues lipidiques polyethyleneglycol-dialkyloxypropyle et utilisations de ces composes |
| US7189705B2 (en) | 2000-04-20 | 2007-03-13 | The University Of British Columbia | Methods of enhancing SPLP-mediated transfection using endosomal membrane destabilizers |
| WO2009153888A1 (fr) | 2008-06-19 | 2009-12-23 | 日本新薬株式会社 | Vecteur de médicament |
| US7982027B2 (en) | 2003-07-16 | 2011-07-19 | Protiva Biotherapeutics, Inc. | Lipid encapsulated interfering RNA |
| US8492359B2 (en) | 2008-04-15 | 2013-07-23 | Protiva Biotherapeutics, Inc. | Lipid formulations for nucleic acid delivery |
| US8569256B2 (en) | 2009-07-01 | 2013-10-29 | Protiva Biotherapeutics, Inc. | Cationic lipids and methods for the delivery of therapeutic agents |
| US9006417B2 (en) | 2010-06-30 | 2015-04-14 | Protiva Biotherapeutics, Inc. | Non-liposomal systems for nucleic acid delivery |
| US9018187B2 (en) | 2009-07-01 | 2015-04-28 | Protiva Biotherapeutics, Inc. | Cationic lipids and methods for the delivery of therapeutic agents |
| US9181545B2 (en) | 2004-06-07 | 2015-11-10 | Protiva Biotherapeutics, Inc. | Lipid encapsulating interfering RNA |
| US9492386B2 (en) | 2002-06-28 | 2016-11-15 | Protiva Biotherapeutics, Inc. | Liposomal apparatus and manufacturing methods |
| US9878042B2 (en) | 2009-07-01 | 2018-01-30 | Protiva Biotherapeutics, Inc. | Lipid formulations for delivery of therapeutic agents to solid tumors |
| CN112285247A (zh) * | 2020-12-30 | 2021-01-29 | 南京广祺医药科技有限公司 | 一种定量测定血浆中PEGylated-IL-2(1A)的方法及应用 |
| CN114209829A (zh) * | 2021-12-17 | 2022-03-22 | 中国科学技术大学 | 负载荧光染料的光热脂质体及其制备方法和用途 |
| CN114740110A (zh) * | 2022-03-31 | 2022-07-12 | 天津键凯科技有限公司 | 一种二硬脂酰磷脂酰胆碱纯度的检测方法 |
| US11591544B2 (en) | 2020-11-25 | 2023-02-28 | Akagera Medicines, Inc. | Ionizable cationic lipids |
-
1999
- 1999-05-13 CA CA 2271582 patent/CA2271582A1/fr not_active Abandoned
Cited By (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7189705B2 (en) | 2000-04-20 | 2007-03-13 | The University Of British Columbia | Methods of enhancing SPLP-mediated transfection using endosomal membrane destabilizers |
| WO2001080900A3 (fr) * | 2000-04-20 | 2003-04-24 | Univ British Columbia | Procedes permettant d'ameliorer la transfection a mediation splp (particule plasmide-lipide stabilisee) au moyen de destabilisateurs de la membrane endosomale |
| WO2001080900A2 (fr) * | 2000-04-20 | 2001-11-01 | The University Of British Columbia | Procedes permettant d'ameliorer la transfection a mediation splp (particule plasmide-lipide stabilisee) au moyen de destabilisateurs de la membrane endosomale |
| US11298320B2 (en) | 2002-06-28 | 2022-04-12 | Arbutus Biopharma Corporation | Liposomal apparatus and manufacturing methods |
| US9492386B2 (en) | 2002-06-28 | 2016-11-15 | Protiva Biotherapeutics, Inc. | Liposomal apparatus and manufacturing methods |
| US9504651B2 (en) | 2002-06-28 | 2016-11-29 | Protiva Biotherapeutics, Inc. | Lipid compositions for nucleic acid delivery |
| US11318098B2 (en) | 2002-06-28 | 2022-05-03 | Arbutus Biopharma Corporation | Liposomal apparatus and manufacturing methods |
| US7982027B2 (en) | 2003-07-16 | 2011-07-19 | Protiva Biotherapeutics, Inc. | Lipid encapsulated interfering RNA |
| US7803397B2 (en) | 2003-09-15 | 2010-09-28 | Protiva Biotherapeutics, Inc. | Polyethyleneglycol-modified lipid compounds and uses thereof |
| WO2005026372A1 (fr) * | 2003-09-15 | 2005-03-24 | Protiva Biotherapeutics, Inc. | Composes conjugues lipidiques polyethyleneglycol-dialkyloxypropyle et utilisations de ces composes |
| US8936942B2 (en) | 2003-09-15 | 2015-01-20 | Protiva Biotherapeutics, Inc. | Polyethyleneglycol-modified lipid compounds and uses thereof |
| US9181545B2 (en) | 2004-06-07 | 2015-11-10 | Protiva Biotherapeutics, Inc. | Lipid encapsulating interfering RNA |
| US9926560B2 (en) | 2004-06-07 | 2018-03-27 | Protiva Biotherapeutics, Inc. | Lipid encapsulating interfering RNA |
| US11141378B2 (en) | 2008-04-15 | 2021-10-12 | Arbutus Biopharma Corporation | Lipid formulations for nucleic acid delivery |
| US8492359B2 (en) | 2008-04-15 | 2013-07-23 | Protiva Biotherapeutics, Inc. | Lipid formulations for nucleic acid delivery |
| US9364435B2 (en) | 2008-04-15 | 2016-06-14 | Protiva Biotherapeutics, Inc. | Lipid formulations for nucleic acid delivery |
| US8822668B2 (en) | 2008-04-15 | 2014-09-02 | Protiva Biotherapeutics, Inc. | Lipid formulations for nucleic acid delivery |
| WO2009153888A1 (fr) | 2008-06-19 | 2009-12-23 | 日本新薬株式会社 | Vecteur de médicament |
| US11446383B2 (en) | 2009-07-01 | 2022-09-20 | Arbutus Biopharma Corporation | Lipid formulations for delivery of therapeutic agents |
| US9878042B2 (en) | 2009-07-01 | 2018-01-30 | Protiva Biotherapeutics, Inc. | Lipid formulations for delivery of therapeutic agents to solid tumors |
| US8569256B2 (en) | 2009-07-01 | 2013-10-29 | Protiva Biotherapeutics, Inc. | Cationic lipids and methods for the delivery of therapeutic agents |
| US9018187B2 (en) | 2009-07-01 | 2015-04-28 | Protiva Biotherapeutics, Inc. | Cationic lipids and methods for the delivery of therapeutic agents |
| US11786598B2 (en) | 2009-07-01 | 2023-10-17 | Arbutus Biopharma Corporation | Lipid formulations for delivery of therapeutic agents |
| US9404127B2 (en) | 2010-06-30 | 2016-08-02 | Protiva Biotherapeutics, Inc. | Non-liposomal systems for nucleic acid delivery |
| US11718852B2 (en) | 2010-06-30 | 2023-08-08 | Arbutus Biopharma Corporation | Non-liposomal systems for nucleic acid delivery |
| US9006417B2 (en) | 2010-06-30 | 2015-04-14 | Protiva Biotherapeutics, Inc. | Non-liposomal systems for nucleic acid delivery |
| US9518272B2 (en) | 2010-06-30 | 2016-12-13 | Protiva Biotherapeutics, Inc. | Non-liposomal systems for nucleic acid delivery |
| US11591544B2 (en) | 2020-11-25 | 2023-02-28 | Akagera Medicines, Inc. | Ionizable cationic lipids |
| CN112285247A (zh) * | 2020-12-30 | 2021-01-29 | 南京广祺医药科技有限公司 | 一种定量测定血浆中PEGylated-IL-2(1A)的方法及应用 |
| CN114209829A (zh) * | 2021-12-17 | 2022-03-22 | 中国科学技术大学 | 负载荧光染料的光热脂质体及其制备方法和用途 |
| CN114209829B (zh) * | 2021-12-17 | 2023-03-17 | 中国科学技术大学 | 负载荧光染料的光热脂质体及其制备方法和用途 |
| CN114740110A (zh) * | 2022-03-31 | 2022-07-12 | 天津键凯科技有限公司 | 一种二硬脂酰磷脂酰胆碱纯度的检测方法 |
| CN114740110B (zh) * | 2022-03-31 | 2023-10-24 | 天津键凯科技有限公司 | 一种二硬脂酰磷脂酰胆碱纯度的检测方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6858225B2 (en) | Lipid-encapsulated polyanionic nucleic acid | |
| EP2567693B1 (fr) | ARN interférents encapsulés dans des lipides | |
| US6835395B1 (en) | Composition containing small multilamellar oligodeoxynucleotide-containing lipid vesicles | |
| Hope et al. | Cationic lipids, phosphatidylethanolamine and the intracellular delivery of polymeric, nucleic acid-based drugs | |
| US5705385A (en) | Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer | |
| US6534484B1 (en) | Methods for encapsulating plasmids in lipid bilayers | |
| EP2892505B1 (fr) | Ensembles lipides comprenant des lysolipides anioniques et leur utilisation | |
| KR101954912B1 (ko) | 이미노 지질을 포함하는 양쪽성 리포좀 | |
| CA2271582A1 (fr) | Procede d'administration d'agents therapeutiques, incluant l'anti-sens avec dosage repetitif | |
| EP2113247A2 (fr) | Encapsulation hautement éfficace d'acides nucléiques dans des vésicules lipidiques |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Dead |